Concepedia

Publication | Open Access

Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor

DOIFull Paper Access

169

Citations

33

References

2011

Year

Robert Mallon, Larry Feldberg, Judy Lucas, Christoph M. Dehnhardt, Efren Delos Santos, Zecheng Chen, Osvaldo dos Santos, Semiramis Ayral‐Kaloustian, Aranapakam M. Venkatesan, Irwin Hollander
Clinical Cancer Research

Abstract

Significant antitumor efficacy and a favorable pharmacokinetic/safety profile justified phase 1 clinical evaluation of PKI-587.

References

YearCitations

Page 1